CSF Aβ42, p-tau181 and several plasma p-tau biomarkers (such as p-tau 231) can be used in a specialized memory clinic as a stand-alone biomarker to detect biologically-defined AD (35, 36). Here, MAPT is linked to Alzheimer disease.